EGRX logo

Eagle Pharmaceuticals, Inc.

EGRX

EGRX: Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

more

Show EGRX Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of EGRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by EGRX's directors and management

Government lobbying spending instances

  • $30,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 17, 2023 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 18, 2023 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 23, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 22, 2021 Issue: Health Issues Medicare/Medicaid
  • $40,000 Jul 20, 2021 Issue: Medicare/Medicaid Pharmacy
  • $30,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $60,000 Apr 20, 2021 Issue: Medicare/Medicaid Pharmacy
  • $80,000 Jan 21, 2021 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 20, 2020 Issue: Health Issues
  • $30,000 Apr 21, 2020 Issue: Health Issues
  • $30,000 Jan 21, 2020 Issue: Health Issues
  • $30,000 Oct 18, 2019 Issue: Health Issues
  • $30,000 Mar 08, 2018 Issue: Health Issues
  • $30,000 Jan 12, 2018 Issue: Health Issues
  • $45,000 Oct 13, 2017 Issue: Health Issues
  • $20,000 Oct 12, 2017 Issue: Health Issues
  • $45,000 Jul 03, 2017 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of EGRX in WallStreetBets Daily Discussion

EGRX News

Recent insights relating to EGRX

CNBC Recommendations

Recent picks made for EGRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EGRX

Corporate Flights

Flights by private jets registered to EGRX